Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
A randomized trial of glutamine and antioxidants in critically ill patients.
|
N Engl J Med
|
2013
|
8.94
|
2
|
High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial.
|
JAMA
|
2014
|
4.53
|
3
|
Vitamin C pharmacokinetics: implications for oral and intravenous use.
|
Ann Intern Med
|
2004
|
4.30
|
4
|
The role of neutrophils in myocardial ischemia-reperfusion injury.
|
Cardiovasc Res
|
1999
|
2.27
|
5
|
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy.
|
Ann Oncol
|
2008
|
2.27
|
6
|
Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients.
|
Ann Surg
|
2002
|
1.92
|
7
|
Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: outcome of a randomized, controlled, double-blind trial.
|
Crit Care Med
|
2008
|
1.71
|
8
|
Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study.
|
Arch Surg
|
2000
|
1.63
|
9
|
Impact of high-dose antioxidants on outcomes in acutely injured patients.
|
JPEN J Parenter Enteral Nutr
|
2008
|
1.52
|
10
|
Fundamentals of reperfusion injury for the clinical cardiologist.
|
Circulation
|
2002
|
1.49
|
11
|
Postresuscitation syndrome: potential role of hydroxyl radical-induced endothelial cell damage.
|
Crit Care Med
|
2011
|
1.47
|
12
|
Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries.
|
Adv Nutr
|
2011
|
1.45
|
13
|
Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients.
|
Crit Care
|
2008
|
1.34
|
14
|
Post cardiac arrest syndrome: a review of therapeutic strategies.
|
Circulation
|
2011
|
1.26
|
15
|
Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk.
|
Crit Care Med
|
1996
|
1.19
|
16
|
Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis.
|
J Transl Med
|
2014
|
1.17
|
17
|
Postischemic renal oxidative stress induces inflammatory response through PAF and oxidized phospholipids. Prevention by antioxidant treatment.
|
FASEB J
|
2002
|
1.10
|
18
|
A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.
|
P R Health Sci J
|
2005
|
1.08
|
19
|
Leucocyte ascorbic acid levels after acute myocardial infarction.
|
Br Heart J
|
1972
|
1.08
|
20
|
Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer.
|
Cancer Chemother Pharmacol
|
2013
|
1.07
|
21
|
Ascorbic acid dynamics in the seriously ill and injured.
|
J Surg Res
|
2003
|
1.07
|
22
|
Vitamin C revisited.
|
Crit Care
|
2014
|
1.01
|
23
|
Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells.
|
J Cardiovasc Pharmacol
|
2001
|
0.94
|
24
|
Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?
|
Crit Care
|
2015
|
0.93
|
25
|
Nitric oxide mediates tightening of the endothelial barrier by ascorbic acid.
|
Biochem Biophys Res Commun
|
2010
|
0.89
|
26
|
EuReCa ONE - ONE month - ONE Europe - ONE goal.
|
Resuscitation
|
2014
|
0.83
|
27
|
Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/reperfusion in rats.
|
J Hepatol
|
2002
|
0.82
|
28
|
The effect of vitamin C on ischemia reperfusion injury because of prolonged tourniquet application with reperfusion intervals.
|
Ann Plast Surg
|
2009
|
0.78
|
29
|
Combination of intravenous ascorbic acid administration and hypothermia after resuscitation improves myocardial function and survival in a ventricular fibrillation cardiac arrest model in the rat.
|
Acad Emerg Med
|
2014
|
0.78
|
30
|
Hydrocortisone, Vitamin C and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
|
Chest
|
2016
|
0.77
|